Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1Phase 3 1Phase 1/2 1Phase 1 1

Status

Active not recruiting 3Recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 5INDUSTRY 2

Study Type

Interventional 7Observational 1

Sponsor

Cancer Type

CNS 7Breast 6

Conditions

Breast Neoplasms 59Neoplasm Metastasis 24Stomach Neoplasms 12Carcinoma, Non-Small-Cell Lung 11Colorectal Neoplasms 10Neoplasms 8Brain Neoplasms 7Triple Negative Breast Neoplasms 5Adenocarcinoma 5Recurrence 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Esophageal Neoplasms 3Endometrial Neoplasms 3Advanced Solid Tumor 3Salivary Gland Neoplasms 2Meningeal Carcinomatosis 2HER2-positive Breast Cancer 2Colonic Neoplasms 2Breast Cancer With Brain Metastasis 2Advanced Breast Cancer 2Adenocarcinoma Of Esophagus 2Uterine Neoplasms 1Unresectable Locally Recurrent Breast Cancer 1Solid Cancer 1Sarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Osteosarcoma 1

Interventions

Temozolomide 162Radiosurgery 115Radiotherapy 100Bevacizumab 96Magnetic Resonance Spectroscopy 65Carboplatin 48Etoposide 34pembrolizumab 33Surgical Procedures, Operative 33Irinotecan 33Nivolumab 32Cyclophosphamide 32Erlotinib Hydrochloride 31Radiation 30Carmustine 28Lomustine 25Cisplatin 25Trastuzumab 23Ipilimumab 23Filgrastim 23Vincristine 20Mental Status and Dementia Tests 20Aminolevulinic Acid 19Topotecan 18Pemetrexed 18Capecitabine 18Specimen Handling 17Sorafenib 15Radiotherapy, Intensity-Modulated 15Imatinib Mesylate 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Interventional × Brain Neoplasms × trastuzumab deruxtecan × Clear all
NCT04739761 2026-05-12

DESTINY-B12

AstraZeneca

Phase 3 Active not recruiting
506 enrolled 27 charts
BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT06048718 2026-05-08

TUXEDO-4

MedSIR

Phase 2 Active not recruiting
28 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT07454668 2026-03-06

Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases

Baptist Health South Florida

Phase 1 Not yet recruiting
20 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT05376878 2026-02-23

An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis

City of Hope Medical Center

Phase 4 Recruiting
10 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT06058988 2026-02-23

Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
30 enrolled
CNS

Brain Neoplasms, Glioblastoma, Neoplasm Metastasis, Meningeal Carcinomatosis

NCT04538742 2025-12-08

DB-07

AstraZeneca

Phase 1/2 Active not recruiting
245 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT04420598 2025-06-24

DEBBRAH

MedSIR

Phase 2 Completed
41 enrolled 32 charts
BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡